Guangzhou Renheng Pharmaceutical Technology

Guangzhou Renheng Pharmaceutical Technology is a China-based pharmaceutical company specializing in the research, development, and commercialization of chemical improved drugs and high-end generic medications. The company focuses on therapeutic areas such as ophthalmology, antivirals, pediatrics, and cardiovascular health, leveraging advanced formulation technologies like sustained-release and microcrystalline nano-platforms. Listed on the New Third Board (NEEQ: 870511), Renheng also provides comprehensive CRO and CDMO services, including consistency evaluation and drug import registration. With multiple R&D and manufacturing bases in Guangzhou, the company aims to enhance the clinical accessibility of high-quality medicines through innovation and strategic partnerships.